DG vs SLRX · P/E 15, rev $22.08B vs $4.9M cap
Dollar General Corporation (DG) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported DG revenue for 2026-07-31 was $22.08B. Net income was $994.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
DG currently screens at market cap $22.87B and trailing P/E 14.7. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the DG and SLRX stock pages for the full models.
Not investment advice.